Background: Hydatid cyst is one of the most important and dangerous human and herbivore animal helminthic disease. Infection is quite prevalent in Iran, however, patients' features and manifestations have not been clarified thoroughly, thus, in the present study we evaluated Iranian patients with hydatid cyst referred to a tertiary hospital in Tehran during a 20-year period (1984 2004). Materials and Methods: For this descriptive study, initial data including age, sex, clinical symptoms, cyst type, the place of cyst replacement, diagnostic technique, laboratory findings, treatment modalities and relapse were obtained from patients medical files. Results: Totally, 60 patients aged 4 70 years were entered, of whom 32 (53.3%) were females and 28 (46.7%) were males. House-wives (75%) and farmer men (42.8%) were more commonly affected. In 80% of the cases cyst was found in liver (lonely or with other organ involvement). Echinococcous Granulosus was detected in all patients. RUQ pain and cough and sputum were the most common symptoms of liver and lung cysts, respectively. Totally, 20% of patients referred with relapses, most of whom were multivesicular. Conclusion: Our results revealed that hydatid cyst in Iran is more or less the same as other western societies, however, a high rate of relapse in multivesicular cysts was noted.
PP-187 Investigation on anti-leishmanial effects of artemisinin in comparison with glucantim on Leishmania major in vitro Background: This work was to evaluate the chemo prophylactic effect of artemether on different S. mansoni developmental stages. Methods: Male albino mice were infected with 80±10 of S. mansoni cercariae, and then classified into 7 groups each of 10 mice. Infected-untreated mice (A), PZQ-treated 42 days PI in a dose 500 mg/kg/b. wt. for two consecutive days (B), whereas in groups (C, D, E, F and G) mice were treated with artemether at five different time periods 7, 14, 21 and 45 days post infection and 2 days before infection, respectively in a dose (50 mg/kg/b.wt.). Parasitological and histopathological criteria were employed.
Results:
The results of the present study suggest that i.m dose of 50 mg/kg artemether at 7, 14 and 21 days PI were efficacies against S. mansoni with total worm reduction (73.10%, 77.43% and 87.15%, respectively). Furthermore, there was a significant decline (P < 0.001) in the mean granuloma number as well as the mean granuloma diameter.
Conclusion: It was concluded that artemether could be a promising agent in the control of schistosomiasis mansoni; also it has a potentiality in improving the hepatic lesions. Furthermore, it is effective as a chemo prophylactic agent.
